The SGCB gene is associated with limb-girdle muscular dystrophy type 2E (LGMD2E), a genetic condition characterized by progressive muscle weakness and atrophy, particularly affecting the hip and shoulder muscles. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The genetic test for LGMD2E specifically examines the SGCB gene for mutations known to cause the disorder. This test is crucial for accurate diagnosis, enabling targeted treatment and management strategies, and providing valuable information for family planning.
At DNA Labs UAE, the test for SGCB gene mutations associated with limb-girdle muscular dystrophy autosomal recessive type 2E is offered at a cost of 4400 AED. The testing process involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the SGCB gene. Results from this test can help confirm a diagnosis of LGMD2E, guide treatment decisions, and provide important information for genetic counseling.
The TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G (LGMD2G) Genetic Test is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify mutations in the TCAP gene. These mutations are responsible for causing Limb-Girdle Muscular Dystrophy type 2G, a rare genetic disorder characterized by progressive weakness and wasting of the limb muscles as well as the muscles around the hips and shoulders (the limb-girdle area). This condition is inherited in an autosomal recessive pattern, meaning that an individual must receive a defective gene from each parent to be affected.
The test is crucial for accurate diagnosis, enabling early intervention and management of the condition. It involves analyzing the patient's DNA to look for specific genetic alterations in the TCAP gene that are indicative of LGMD2G. By identifying the genetic underpinnings of the disease, healthcare providers can offer targeted advice on treatment options and genetic counseling for affected families.
The cost of the TCAP Gene Limb-Girdle Muscular Dystrophy autosomal recessive type 2G Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of the specific gene mutations associated with the condition, providing essential information for affected individuals and their families regarding the prognosis and potential management strategies for LGMD2G.
The TRIM32 gene limb-girdle muscular dystrophy autosomal recessive type 2H genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TRIM32 gene. These mutations are responsible for causing limb-girdle muscular dystrophy type 2H (LGMD2H), a condition characterized by progressive weakness and wasting of the muscles around the hips and shoulders. This form of muscular dystrophy is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition.
The test involves analyzing the patient's DNA to search for specific genetic alterations in the TRIM32 gene that are known to cause LGMD2H. Early diagnosis through genetic testing is crucial for managing symptoms, implementing appropriate treatment plans, and providing genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is conducted in a state-of-the-art laboratory setting by a team of expert geneticists and technicians, ensuring accurate and reliable results. Patients opting for this test can expect a thorough analysis of the TRIM32 gene, which will aid in confirming a diagnosis of limb-girdle muscular dystrophy type 2H, potentially guiding treatment decisions and helping to assess the risk of passing the condition on to future generations.
The FKRP gene limb-girdle muscular dystrophy autosomal recessive type 2I genetic test is a specialized diagnostic tool designed to detect mutations in the FKRP gene, which are responsible for causing limb-girdle muscular dystrophy type 2I (LGMD2I). This form of muscular dystrophy is characterized by progressive muscle weakness and wasting, primarily affecting the muscles around the hips and shoulders (the limb-girdle area). It is inherited in an autosomal recessive manner, meaning that two copies of the defective gene, one from each parent, are required for the condition to manifest.
The test involves analyzing the patient's DNA, extracted from a blood sample, to identify mutations in the FKRP gene that are linked to LGMD2I. This genetic test is crucial for accurate diagnosis, allowing for early intervention, management plans, and genetic counseling for affected families. It also helps in distinguishing LGMD2I from other forms of muscular dystrophy and related disorders.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic analysis, ensuring high-quality testing and reliable results. This test is an essential resource for individuals exhibiting symptoms of limb-girdle muscular dystrophy, as well as for their families seeking to understand their genetic health and risks.
The TTN gene limb-girdle muscular dystrophy autosomal recessive type 2J genetic test is a specialized diagnostic tool designed to identify mutations in the TTN gene, which are responsible for causing limb-girdle muscular dystrophy type 2J (LGMD2J). This form of muscular dystrophy is characterized by progressive weakness and wasting of the limb-girdle muscles, which include the shoulders and hips. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease.
DNA Labs UAE offers this genetic test, providing a crucial service for individuals and families seeking to understand their genetic status in relation to LGMD2J. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the TTN gene.
The cost of the TTN gene limb-girdle muscular dystrophy autosomal recessive type 2J genetic test at DNA Labs UAE is 4400 AED. This cost covers the full process of the test, from sample collection to genetic analysis and reporting of results. The results from this test can provide valuable information for affected individuals and their families, including the confirmation of a diagnosis, insights into the prognosis of the disease, and guidance for genetic counseling and family planning.
The ANO5 gene limb-girdle muscular dystrophy autosomal recessive type 2L (LGMDR2, formerly LGMD2L) genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the ANO5 gene that are associated with this specific form of muscular dystrophy. Limb-girdle muscular dystrophy is a group of genetic disorders characterized by progressive muscle weakness and atrophy, primarily affecting the muscles around the hips and shoulders (the limb-girdle area). The autosomal recessive type 2L variant, associated with mutations in the ANO5 gene, is one of the many subtypes of this condition.
The test, which costs 4400 AED, involves analyzing the patient's DNA to detect mutations in the ANO5 gene that are known to cause LGMDR2. It is a crucial step for patients showing symptoms of muscular dystrophy, as a definitive genetic diagnosis can help in understanding the progression of the disease, inform treatment options, and allow for genetic counseling for the family. Conducted at DNA Labs UAE, this test is an important resource for individuals and families seeking answers about this specific form of limb-girdle muscular dystrophy.
The FKTN gene limb-girdle muscular dystrophy autosomal recessive type 2M genetic test is a specialized diagnostic examination aimed at detecting mutations in the FKTN gene, which are responsible for causing limb-girdle muscular dystrophy type 2M (LGMD2M). This condition is a form of muscular dystrophy that affects the voluntary muscles around the hips and shoulders (the limb-girdle muscles), leading to muscle weakness and wasting. As an autosomal recessive disorder, LGMD2M requires two copies of the defective gene—one from each parent—for a person to be affected.
DNA Labs UAE offers this genetic test as a critical tool for confirming the diagnosis of LGMD2M, enabling healthcare professionals to tailor treatment and management plans according to the specific needs of the patient. The test involves analyzing the patient's DNA to identify mutations in the FKTN gene, which provides instructions for making a protein involved in maintaining muscle cell structure and function.
The cost of the FKTN gene limb-girdle muscular dystrophy autosomal recessive type 2M genetic test at DNA Labs UAE is 4400 AED. By conducting this test, families affected by LGMD2M can also receive genetic counseling to understand the implications of the results, the risk of passing the condition to future generations, and the options available for family planning.
The POMT1 gene plays a crucial role in the development and maintenance of muscle tissue. Mutations in this gene can lead to a specific form of limb-girdle muscular dystrophy, classified as autosomal recessive type 2N (LGMDR2, formerly LGMD2N). This condition is characterized by progressive weakness and wasting of the limb-girdle muscles, which are the muscles around the shoulders and hips. Symptoms typically begin in childhood or adolescence and can vary widely in severity.
To diagnose this condition and differentiate it from other forms of muscular dystrophy, genetic testing is essential. DNA Labs UAE offers a specialized test targeting the POMT1 gene to identify mutations associated with LGMDR2. The test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific genetic alterations in the POMT1 gene that are known to cause the disease.
The cost of the POMT1 gene limb-girdle muscular dystrophy autosomal recessive type 2N genetic test at DNA Labs UAE is 4400 AED. This test is a crucial step in confirming the diagnosis, which can help in managing the condition more effectively through personalized treatment plans and genetic counseling for affected families. It also provides valuable information for understanding the prognosis and potential participation in clinical trials or therapies targeting the underlying genetic cause.
The "DCX Gene Lissencephaly/Subcortical Band Heterotopia (SBH) X-linked Genetic Test" is a specialized diagnostic tool used to identify mutations in the DCX gene, which are linked to neurodevelopmental disorders such as Lissencephaly and Subcortical Band Heterotopia (SBH). These conditions are characterized by abnormal brain formation, leading to smooth brain surfaces (lissencephaly) or irregular bands of gray matter (SBH), which can result in severe intellectual disability, developmental delay, seizures, and motor impairment. Given the X-linked inheritance pattern, males are typically more severely affected, while females may have milder symptoms.
This genetic test, offered by DNA Labs UAE for a cost of 4400 AED, involves analyzing the patient's DNA to detect mutations in the DCX gene that are responsible for these conditions. The test is crucial for accurate diagnosis, understanding the risk of recurrence in families, and guiding clinical management. It is performed in a state-of-the-art laboratory setting, ensuring high-quality, reliable results for affected families seeking answers and support for these challenging conditions.
The OCRL Gene Lowe oculocerebrorenal syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the OCRL gene, which are associated with Lowe syndrome. Lowe syndrome, also known as oculocerebrorenal syndrome, is a rare genetic disorder characterized by eye abnormalities, brain abnormalities, and kidney problems. This condition primarily affects males and can lead to a range of symptoms including cataracts, muscle weakness, intellectual disability, and renal impairment.
DNA Labs UAE provides this genetic testing service for individuals who may be at risk of having Lowe syndrome, or for families looking to understand their genetic health background. By analyzing the OCRL gene, this test can confirm a diagnosis of Lowe syndrome, assist in the management of the condition, and provide crucial information for family planning.
The cost of the OCRL Gene Lowe oculocerebrorenal syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the detailed analysis required to detect any mutations in the OCRL gene. Given the complexity of genetic testing and the specific expertise required to interpret the results, this test is a critical tool in the diagnosis and management of Lowe syndrome, offering patients and their families the information needed to navigate the condition with greater understanding and preparedness.
